Exelixis
Trade Exelixis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About EXEL
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
Exelixis(EXEL) stock is priced at $54.96, giving the company a market capitalization of 13.93B. It carries a P/E multiple of 17.88.
On 2026-07-02, Exelixis(EXEL) stock moved within a range of $54.00 to $56.20. With shares now at $54.96, the stock is trading +1.8% above its intraday low and -2.2% below the session's peak.
Trading activity shows a volume of 1.31M, compared to an average daily volume of 3.38M.
The stock's 52-week range extends from a low of $33.76 to a high of $56.20.
The stock's 52-week range extends from a low of $33.76 to a high of $56.20.
EXEL News
UBS analyst Ashwani Verma raised the firm’s price target on Exelixis (EXEL) to $52 from $43 and keeps a Neutral rating on the shares. The stock is resilient, bu...
Exelixis (EXEL) shares are in focus after the company reported final subgroup data from its phase 3 STELLAR-303 trial of zanzalintinib plus atezolizumab in meta...
Analyst ratings
50%
of 20 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.